Stay updated on Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Sign up to get notified when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A consolidated 'Locations' section appears, including California and Georgia sites, replacing the separate 'California Locations' and 'Georgia Locations' subsections; the footer 'HHS Vulnerability Disclosure' link has been removed.
    Difference
    0.4%
    Check dated 2025-12-23T17:13:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2 instead of Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:45:17.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Removed the site-wide notice about a lapse in government funding and potential processing delays, including references to cc.nih.gov and opm.gov. This change does not affect core trial information or study details.
    Difference
    0.4%
    Check dated 2025-11-17T19:49:55.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new page; only minor formatting or layout differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:52:47.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.
    Difference
    5%
    Check dated 2025-10-06T04:25:49.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Expanded topic coverage to include Sudden Infant Death Syndrome and related terms, with a new revision v3.1.0; previous revision v3.0.2 removed.
    Difference
    1%
    Check dated 2025-09-29T00:58:27.000Z thumbnail image

Stay in the know with updates to Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.